Agenus
AGEN
#8307
Rank
C$0.43 B
Marketcap
C$10.51
Share price
-5.18%
Change (1 day)
42.28%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): C$0.16 Billion

According to Agenus 's latest financial reports the company's current earnings are C$0.12 Billion. In 2025 the company made an earning of C$73.15 Million, an increase over its 2024 earnings that were of -C$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.16 B128.12%
2025 C$73.15 M-145.52%
2024 -C$0.17 Billion-28.13%
2023 -C$0.23 Billion-5.5%
2022 -C$0.24 Billion-556.26%
2021 C$51.85 M-130.37%
2020 -C$0.18 Billion73.75%
2019 -C$98.28 Million-48.74%
2018 -C$0.2 Billion34.32%
2017 -C$0.15 Billion-7.16%
2016 -C$0.16 Billion26.55%
2015 -C$0.13 Billion110.24%
2014 -C$57.79 Million49.12%
2013 -C$38.75 Million
2011 -C$26.76 Million-12.25%
2010 -C$30.5 Million-21.41%
2009 -C$38.8 Million-26.86%
2008 -C$53.05 Million13.72%
2007 -C$46.65 Million-33.4%
2006 -C$70.05 Million-31.84%
2005 -C$0.11 Billion9.74%
2004 -C$93.64 Million-0.8%
2003 -C$94.4 Million17.37%
2002 -C$80.43 Million37.83%
2001 -C$58.35 Million55.99%
2000 -C$37.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.41 B 21,614.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.43 B 10,892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.45 B 7,921.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$14.03 B 8,267.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-C$0.44 Billion-358.33%๐Ÿ‡บ๐Ÿ‡ธ USA